Status:
COMPLETED
Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events
Lead Sponsor:
Universidade Estadual de Londrina
Conditions:
Uremia
Chronic Renal Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Homocysteine recently gained access to the category of risk factor for the development of atherosclerotic cardiovascular disease in the general population. Chronic renal failure patients, even before ...
Detailed Description
We conducted a double blind , randomized, placebo controlled trial, for two years, enroling, simultaneously, 186 end-stage kidney disease patients of any cause, older than 18 years of age, stable on h...
Eligibility Criteria
Inclusion
- Patients stable on hemodialysis for 4 months or more
- Eighteen years of age or older
Exclusion
- Potential kidney transplant from a living donor in the near future
- Severe cardiovascular disease
- Cancer and active inflammation
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT00317005
Start Date
April 1 2003
End Date
March 1 2005
Last Update
July 26 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario regional do Note do Parana
Londrina, Paraná, Brazil, 86020-320
2
University Hospital, State University of Londrina
Londrina, Paraná, Brazil, 86020-320